Dr. Reddy's buys certain drugs sold in India by UCB
Executive Summary
UCB Group sold a portfolio of drugs it markets in India to Dr. Reddy’s Laboratories Ltd. for $130mm, on what the companies call a “slump sale” basis.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- Marketing (Licensing)
- Product Purchase
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice